Study To Evaluate The Safety And Efficacy Of ILV-094 In Subjects With Rheumatoid Arthritis
Status:
Completed
Trial end date:
2011-02-01
Target enrollment:
Participant gender:
Summary
The primary objective of this study is to assess the safety and efficacy of different dose
regimens of ILV-094 compared with placebo, administered subcutaneously to subjects with
active rheumatoid arthritis who are taking methotrexate.